Poage, A.C.; Rowe, J.M.; Dameron, M.B.A.; Bavuso, A.M.; Smith, A.J.
Comparison of Subcutaneous Versus Intramuscular Estradiol Administration for Feminizing Gender-Affirming Hormone Therapy. Pharmacy 2026, 14, 13.
https://doi.org/10.3390/pharmacy14010013
AMA Style
Poage AC, Rowe JM, Dameron MBA, Bavuso AM, Smith AJ.
Comparison of Subcutaneous Versus Intramuscular Estradiol Administration for Feminizing Gender-Affirming Hormone Therapy. Pharmacy. 2026; 14(1):13.
https://doi.org/10.3390/pharmacy14010013
Chicago/Turabian Style
Poage, Abby C., Jordan M. Rowe, Mary Beth A. Dameron, Abigail M. Bavuso, and Andrew J. Smith.
2026. "Comparison of Subcutaneous Versus Intramuscular Estradiol Administration for Feminizing Gender-Affirming Hormone Therapy" Pharmacy 14, no. 1: 13.
https://doi.org/10.3390/pharmacy14010013
APA Style
Poage, A. C., Rowe, J. M., Dameron, M. B. A., Bavuso, A. M., & Smith, A. J.
(2026). Comparison of Subcutaneous Versus Intramuscular Estradiol Administration for Feminizing Gender-Affirming Hormone Therapy. Pharmacy, 14(1), 13.
https://doi.org/10.3390/pharmacy14010013